Nilsson, Sten
Franzen, Lars
Parker, Christopher; et al.
|
Two-Year Survival Follow-Up of the Randomized, Double-Blind, Placebo-Controlled Phase II Study of Radium-223 Chloride in Patients With Castration-Resistant Prostate Cancer and Bone Metastases
Clinical Genitourinary Cancer,
11(1): 20-26
|
2013
|
-
|
Nilsson, S.
Strang, P.
Aksnes, A. K.; et al.
|
A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of painful bone metastases in patients with castration-resistant prostate cancer
European Journal of Cancer,
48(5): 678-686
|
2012
|
-
|
Zackrisson, Björn
Nilsson, Per
Kjellén, Elisabeth; et al.
|
Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma - The ARTSCAN study
Radiotherapy and Oncology,
100(1): 41-48
|
2011
|
-
|
Daşu, Alexandru
Toma-Daşu, Iuliana
Franzén, Lars; et al.
|
Secondary malignancies from prostate cancer radiation treatment: a risk analysis of the influence of target margins and fractionation patterns
International Journal of Radiation Oncology, Biology, Physics,
79(3): 738-746
|
2011
|
-
|
Dasu, Alexandru
Toma-Dasu, Iuliana
Franzen, Lars; et al.
|
The risk of secondary cancers in patients treated for prostate carcinoma: an analysis with competition dose response model
IFMBE Proceedings: 237-240
|
2009
|
-
|
Dasu, Alexandru
Toma-Dasu, Iuliana
Franzén, Lars; et al.
|
The risk for secondary cancers in patients treated for prostate carcinoma: an analysis with completion dose response model
IFMBE Proceedings of the World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany: 237-240
|
2009
|
-
|
Henriksson, Roger
Capala, Jacek
Michanek, Annika; et al.
|
Boron neutron capture therapy (BNCT) for glioblastoma multiforme.: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Radiother Oncol,
88(2): 183-191
|
2008
|
-
|
Nilsson, Sten
Franzén, Lars
Parker, Christopher; et al.
|
Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study.
The Lancet Oncology,
8(7): 587-594
|
2007
|
-
|
Björeland, Anders
Blomquist, Michael
Sätherberg, Anders; et al.
|
Joint Center - samarbetsprojekt för optimal strålbehandling i närmiljö
Läkartidningen,
101(6): 472-475
|
2004
|
-
|
Löfroth, Per-Olov
Bergström, Per
Forsmark, Cenneth; et al.
|
Penis holder for external radiation treatment
Radiother Oncol,
71(1): 115-116
|
2004
|
-
|
